MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...

Part of this economy makes things — for instance, manufacturing, mining, building. And part of the economy does things — health care, lawyering, internet-ing. In January, according to ADP, the making ...

Expert Blake Emerson discusses the legal ramifications of Elon Musk and the Trump administration's recent economic moves.

Film at Lincoln Center celebrates the documentarian's groundbreaking work this month with a retrospective featuring brand-new ...

FBI agents are suing the Justice Department, alleging retribution over their work on January 6th cases. Former federal prosecutor Chris Mattei, who is representing the seven FBI agents in the case, ...

A source tells NBC News the CIA sent the White House an unclassified email listing the names of recently hired employees. NBC ...

FBI agents involved in the Jan. 6 Capital riot investigations have filed lawsuits against the Justice Department, challenging ...

The use of generative AI in schools is causing a divide in classrooms across the country. While some teachers embrace its use ...

The farewell ceremony for the Grade 10 students of G M Global School, Brahmavar was held in the School Auditorium on February ...

When North Carolina general manager Michael Lombardi offered Navy defensive lineman commit Trey Giddens during a weekend ...

A Louisiana appeals court has upheld the suspension of an LSU law professor who criticized Gov. Jeff Landry and President ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.